Is UroGen Pharma Ltd. technically bullish or bearish?

Nov 05 2025 11:22 AM IST
share
Share Via
As of October 31, 2025, UroGen Pharma Ltd. has shifted to a bullish trend, supported by positive moving averages and Bollinger Bands, despite a mildly bearish MACD signal, and has outperformed the S&P 500 with an 86.01% year-to-date return compared to 16.30%.
As of 31 October 2025, the technical trend for UroGen Pharma Ltd. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals from the daily moving averages and Bollinger Bands on both weekly and monthly time frames. However, the MACD shows a mildly bearish signal on the weekly, indicating some caution.
In terms of performance, UroGen has significantly outperformed the S&P 500 year-to-date with a return of 86.01% compared to the S&P 500's 16.30%. Over the past year, the stock also shows strong performance at 62.38% against the S&P 500's 19.89%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
UroGen Pharma Hits New 52-Week High of $43.92, Up 242.83%
Jul 22 2026 04:33 PM IST
share
Share Via
UroGen Pharma Hits New 52-Week High of $39.52, Up 197.1%
Jul 02 2026 04:48 PM IST
share
Share Via
UroGen Pharma Hits New 52-Week High of $37.88, Up 188%
Jul 01 2026 04:33 PM IST
share
Share Via
UroGen Pharma Hits New 52-Week High of $36.64, Up 182%
Jun 30 2026 05:08 PM IST
share
Share Via
UroGen Pharma Hits New 52-Week High at $35.53, Up 175.25%
Jun 24 2026 04:28 PM IST
share
Share Via